Pharmacy Articles

Pharmacy

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sacco RL - Rates of recurrent stroke were similar in the aspirin + ERDP and clopidogrel groups, although the criterion for non-inferiority was not met. Groups did not differ for the composite end point (13% in each group) or net risk of recurrent stroke or major bleeding event. Risk of intracranial haemorrhage was increased in the aspirin + ERDP group. In patients with ischaemic stroke, aspirin plus extended-release dipyridamole and clopidogrel resulted in similar rates of recurrent stroke.

Related Articles

Patent foramen ovale and cryptogenic stroke: a complex neuro–cardio–vascular problem
Expert Review of Cardiovascular Therapy, 11/12/09    Relevance Score: 68%

Differences Between Ischemic Stroke Subtypes in Vascular Outcomes Support a Distinct Lacunar Ischemic Stroke Arteriopathy. A Prospective, Hospital-Based Study
Stroke, 11/09/09    Relevance Score: 68%

Antiplatelet therapy for prevention of recurrent stroke
Current Treatment Options in Neurology, 10/30/09    Relevance Score: 68%

Predicting recurrent stroke after minor stroke and transient ischemic attack
Expert Review of Cardiovascular Therapy, 10/20/09    Relevance Score: 68%

Statins and stroke prevention
Expert Review of Cardiovascular Therapy, 10/19/09    Relevance Score: 67%

Today in Cardiac/Hypertension...keeping you current

Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy
Current Medical Research and Opinion, 12/10/09

Inotrope and vasopressor use in the emergency department
Emergency Medicine Australasia, 12/10/09

Fyi from human genome sciences: gsk initiates second pivotal phase 3 trial for investigational cardiovascular medication darapladib
Human Genome Sciences, 12/10/09